banner

EdgeBio is Moving

To continue to provide you with the highest quality products, we are moving to a new manufacturing and shipping facility effective January 1, 2017. Our new site, located in Maumee Ohio, offers increased manufacturing capabilities in a more modern facility and will ensure that EdgeBio products retain the same high quality that you have come to expect as well as allow us to expand the range of products that we provide. Please note that the new facility in Maumee Ohio is dedicated solely to product manufacturing and shipping.

Posted in: 

A New Edge Biosystems

Mark Twain is purported to have once said “the reports of my death have been greatly exaggerated” and the same might be true for the “gold standard” DNA sequencing technology that many refer to as CE or Sanger sequencing.  CE sequencing is experiencing a renaissance, thanks in great part to the technology that was purported to hasten its demise – NGS.  As NGS is employed more extensively across the globe and in more applications, especially in clinical diagnostic applications, the need to verify or confirm the large number of variants generated from whole genome sequencing or whole exome se

Posted in: 

A New Chapter

On August 16, Edge BioServ LLC, the Services Division of EdgeBio, entered into agreement to be acquired and become part of GeneDx (www.genedx.com), a division of BioReference Laboratories, Inc. (http://www.genomeweb.com/sequencing/bioreference-laboratories-acquire-edge-bioserv). GeneDx specializes in genetic testing for rare hereditary disorders.

Posted in: 

Clinical Exome Sequencing Services for Labs and Hospitals for in-House Interpretation

We would like to thank Genomeweb for their recent articles regarding the announcement of our CLIA status. If you missed the articles from Genomeweb you can view them here:  Clinical Exome Sequencing and EdgeBio Recieves CLIA Certification

Request a Quote for your Exome Sequencing Project

 

A few weeks ago we received our CLIA certification for next generation sequencing and will offer clinical exome sequencing for large labs and hospitals that can do their own in-house analysis. We will supply aligned sequencing data and leave the interpretation to the customers themselves.

Recieving CLIA Status

EdgeBio CLIA labIt was with great anticipation and excitement that we received our Certificate of Compliance yesterday from the US Dept. of Health and Human Services Centers for Medicare and Medicaid Services. This, paired with our compliance letter from the State of Maryland, means we have been deemed a CLIA lab and can begin to offer our Clinical Exome test under CLIA guidelines. It’s been quite a journey to get here and everyone is quite excited to receive this designation and achieve this milestone.